# Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition

> **NCT01513681** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Lamictal®

## Key facts

- **NCT ID:** NCT01513681
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2002-11
- **Final completion:** 2002-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01513681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01513681, "Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01513681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*